VDAC1 and diabetic cardiomyopathy: Furthermore, silencing VDAC1 expression using lncRNA-H19/miR-675 has been reported to regulate high glucose-induced apoptosis by targeting VDAC1, suggesting a novel therapeutic strategy for diabetic cardiomyopathy [182].